Scholars Central

Research articlePublished 31 Jul 2019

Predicting the Bioequivalence of Ciprofloxacin HCL Tablet-Brands Using In Vitro Dissolution and Rat Intestinal Permeability Tests

Authors: Anes AM Thabit, Omar Khaled Ali, Saddam Al-qabel, Zaid Ali Ahmad, Abdulmomen Ali Hawaej, Osamah Abduljalil, Youssef Al-waari, Ala'a Aldin Al-obaidi, Saddam Al-Shwei

Journal of Chemical and Pharmaceutical Research

Volume 11 · Issue 7 · Pages 13–19

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bioavailability of a drug is critical factor affecting its efficacy. This parameter for every new brand or a new batch of the brand can be tested by in vivo bioequivalence studies on human volunteers where the equivalence in bioavailability of the tested brand is compared to that of an innovator reference one. These studies requires availability of huge budget, qualified personnel and specific technical requirements and hence, unfortunately, are difficult if not impossible to be carried out in poor countries such as Yemen. Therefore, the approaches of using alternative methods such as animal models, under ethical approval, may be suitable alternatives to the expensive in vivo methods. The present study was alongside those alternative approaches as it aimed to predict bioequivalence of ciprofloxacin HCl 500 mg tablet-brands marketed in Yemen using in vitro dissolution and animal intestinal permeability tests. Five test brands and one innovator brand of the drug were investigated in this study. In addition to drug content and in vitro dissolution, the rat intestinal permeability experiment using rat gut sac model, was carried out for each brand. The drug content and dissolution of all brands were within the pharmacopeial limit with exception of one test brand whose cumulative dissolved% was lower than pharmacopeial limit and also not similar to that of the innovator brand. On the other hand, the permeability ratios of only two test brands were within the range of 0.80-1.25. Since the drug has low solubility and permeability, the two brands which showed similar dissolution and permeability to the innovator brand could be predicted to be bioequivalent to it.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Chemical and Pharmaceutical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chemical and Pharmaceutical Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • BylineArticles whose byline prints “Anes AM Thabit”
  • BylineArticles whose byline prints “Omar Khaled Ali”
  • BylineArticles whose byline prints “Saddam Al-qabel”
  • BylineArticles whose byline prints “Zaid Ali Ahmad”
  • BylineArticles whose byline prints “Abdulmomen Ali Hawaej”
  • BylineArticles whose byline prints “Osamah Abduljalil”
  • BylineArticles whose byline prints “Youssef Al-waari”
  • BylineArticles whose byline prints “Ala'a Aldin Al-obaidi”